Global Alzheimer Market Research Report 2023

Alzheimer’s is a neurodegenerative progressive disease. Alzheimer's disease is a type of dementia whichludes a broad group of brain diseasessuch as problems with memorythinkingand behavior for the long term. It is a type of dementia and near about 60-70% of Alzheimer's disease is the cause of dementia. Many researchers consider anrease in the level of protein amyloid in the brain is one of the causes of Alzheimer disease. Older age is the prominent cause of Alzheimer'swhereas there are also some genetic and some other causes of Alzheimer diseases. The exact cause of Alzheimer’s disease is still unknown.

The global Alzheimer market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Alzheimer’s is a neurodegenerative progressive disease. Alzheimer's disease is a type of dementia whichludes a broad group of brain diseasessuch as problems with memorythinkingand behavior for the long term. It is a type of dementia and near about 60-70% of Alzheimer's disease is the cause of dementia. Many researchers consider anrease in the level of protein amyloid in the brain is one of the causes of Alzheimer disease. Older age is the prominent cause of Alzheimer'swhereas there are also some genetic and some other causes of Alzheimer diseases. The exact cause of Alzheimer’s disease is still unknown.

This report aims to provide a comprehensive presentation of the global market for Alzheimer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alzheimer.

The Alzheimer market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Alzheimer market comprehensively. Regional market sizes, concerning products by drug type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Alzheimer companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by drug type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Drug Type

1.2.1 Global Alzheimer Market Size Growth Rate by Drug Type: 2018 VS 2022 VS 2029

1.2.2 Cholinesterase inhibitors

1.2.3 Pipeline Drugs

1.2.4 NMDA receptor antagonist

1.3 Market by Application

1.3.1 Global Alzheimer Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospital Pharmacy

1.3.3 Retail Pharmacy

1.3.4 Online Sales

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Alzheimer Market Perspective (2018-2029)

2.2 Alzheimer Growth Trends by Region

2.2.1 Global Alzheimer Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Alzheimer Historic Market Size by Region (2018-2023)

2.2.3 Alzheimer Forecasted Market Size by Region (2024-2029)

2.3 Alzheimer Market Dynamics

2.3.1 Alzheimer Industry Trends

2.3.2 Alzheimer Market Drivers

2.3.3 Alzheimer Market Challenges

2.3.4 Alzheimer Market Restraints

3.1 Global Top Alzheimer Players by Revenue

3.1.1 Global Top Alzheimer Players by Revenue (2018-2023)

3.1.2 Global Alzheimer Revenue Market Share by Players (2018-2023)

3.2 Global Alzheimer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Alzheimer Revenue

3.4 Global Alzheimer Market Concentration Ratio

3.4.1 Global Alzheimer Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Alzheimer Revenue in 2022

3.5 Alzheimer Key Players Head office and Area Served

3.6 Key Players Alzheimer Product Solution and Service

3.7 Date of Enter into Alzheimer Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Alzheimer Historic Market Size by Drug Type (2018-2023)

4.2 Global Alzheimer Forecasted Market Size by Drug Type (2024-2029)

5.1 Global Alzheimer Historic Market Size by Application (2018-2023)

5.2 Global Alzheimer Forecasted Market Size by Application (2024-2029)

6.1 North America Alzheimer Market Size (2018-2029)

6.2 North America Alzheimer Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Alzheimer Market Size by Country (2018-2023)

6.4 North America Alzheimer Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Alzheimer Market Size (2018-2029)

7.2 Europe Alzheimer Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Alzheimer Market Size by Country (2018-2023)

7.4 Europe Alzheimer Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Alzheimer Market Size (2018-2029)

8.2 Asia-Pacific Alzheimer Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Alzheimer Market Size by Region (2018-2023)

8.4 Asia-Pacific Alzheimer Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Alzheimer Market Size (2018-2029)

9.2 Latin America Alzheimer Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Alzheimer Market Size by Country (2018-2023)

9.4 Latin America Alzheimer Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Alzheimer Market Size (2018-2029)

10.2 Middle East & Africa Alzheimer Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Alzheimer Market Size by Country (2018-2023)

10.4 Middle East & Africa Alzheimer Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Allergan

11.1.1 Allergan Company Detail

11.1.2 Allergan Business Overview

11.1.3 Allergan Alzheimer Introduction

11.1.4 Allergan Revenue in Alzheimer Business (2018-2023)

11.1.5 Allergan Recent Development

11.2 Eisai

11.2.1 Eisai Company Detail

11.2.2 Eisai Business Overview

11.2.3 Eisai Alzheimer Introduction

11.2.4 Eisai Revenue in Alzheimer Business (2018-2023)

11.2.5 Eisai Recent Development

11.3 Novartis

11.3.1 Novartis Company Detail

11.3.2 Novartis Business Overview

11.3.3 Novartis Alzheimer Introduction

11.3.4 Novartis Revenue in Alzheimer Business (2018-2023)

11.3.5 Novartis Recent Development

11.4 Daiichi Sankyo

11.4.1 Daiichi Sankyo Company Detail

11.4.2 Daiichi Sankyo Business Overview

11.4.3 Daiichi Sankyo Alzheimer Introduction

11.4.4 Daiichi Sankyo Revenue in Alzheimer Business (2018-2023)

11.4.5 Daiichi Sankyo Recent Development

11.5 Merz Pharma

11.5.1 Merz Pharma Company Detail

11.5.2 Merz Pharma Business Overview

11.5.3 Merz Pharma Alzheimer Introduction

11.5.4 Merz Pharma Revenue in Alzheimer Business (2018-2023)

11.5.5 Merz Pharma Recent Development

11.6 Pfizer

11.6.1 Pfizer Company Detail

11.6.2 Pfizer Business Overview

11.6.3 Pfizer Alzheimer Introduction

11.6.4 Pfizer Revenue in Alzheimer Business (2018-2023)

11.6.5 Pfizer Recent Development

11.7 Johnson & Johnson

11.7.1 Johnson & Johnson Company Detail

11.7.2 Johnson & Johnson Business Overview

11.7.3 Johnson & Johnson Alzheimer Introduction

11.7.4 Johnson & Johnson Revenue in Alzheimer Business (2018-2023)

11.7.5 Johnson & Johnson Recent Development

11.8 Lundbeck

11.8.1 Lundbeck Company Detail

11.8.2 Lundbeck Business Overview

11.8.3 Lundbeck Alzheimer Introduction

11.8.4 Lundbeck Revenue in Alzheimer Business (2018-2023)

11.8.5 Lundbeck Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Alzheimer Market Size Growth Rate by Drug Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Cholinesterase inhibitors

    Table 3. Key Players of Pipeline Drugs

    Table 4. Key Players of NMDA receptor antagonist

    Table 5. Global Alzheimer Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Alzheimer Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Alzheimer Market Size by Region (2018-2023) & (US$ Million)

    Table 8. Global Alzheimer Market Share by Region (2018-2023)

    Table 9. Global Alzheimer Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 10. Global Alzheimer Market Share by Region (2024-2029)

    Table 11. Alzheimer Market Trends

    Table 12. Alzheimer Market Drivers

    Table 13. Alzheimer Market Challenges

    Table 14. Alzheimer Market Restraints

    Table 15. Global Alzheimer Revenue by Players (2018-2023) & (US$ Million)

    Table 16. Global Alzheimer Market Share by Players (2018-2023)

    Table 17. Global Top Alzheimer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer as of 2022)

    Table 18. Ranking of Global Top Alzheimer Companies by Revenue (US$ Million) in 2022

    Table 19. Global 5 Largest Players Market Share by Alzheimer Revenue (CR5 and HHI) & (2018-2023)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Alzheimer Product Solution and Service

    Table 22. Date of Enter into Alzheimer Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Alzheimer Market Size by Drug Type (2018-2023) & (US$ Million)

    Table 25. Global Alzheimer Revenue Market Share by Drug Type (2018-2023)

    Table 26. Global Alzheimer Forecasted Market Size by Drug Type (2024-2029) & (US$ Million)

    Table 27. Global Alzheimer Revenue Market Share by Drug Type (2024-2029)

    Table 28. Global Alzheimer Market Size by Application (2018-2023) & (US$ Million)

    Table 29. Global Alzheimer Revenue Market Share by Application (2018-2023)

    Table 30. Global Alzheimer Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 31. Global Alzheimer Revenue Market Share by Application (2024-2029)

    Table 32. North America Alzheimer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 33. North America Alzheimer Market Size by Country (2018-2023) & (US$ Million)

    Table 34. North America Alzheimer Market Size by Country (2024-2029) & (US$ Million)

    Table 35. Europe Alzheimer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 36. Europe Alzheimer Market Size by Country (2018-2023) & (US$ Million)

    Table 37. Europe Alzheimer Market Size by Country (2024-2029) & (US$ Million)

    Table 38. Asia-Pacific Alzheimer Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 39. Asia-Pacific Alzheimer Market Size by Region (2018-2023) & (US$ Million)

    Table 40. Asia-Pacific Alzheimer Market Size by Region (2024-2029) & (US$ Million)

    Table 41. Latin America Alzheimer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 42. Latin America Alzheimer Market Size by Country (2018-2023) & (US$ Million)

    Table 43. Latin America Alzheimer Market Size by Country (2024-2029) & (US$ Million)

    Table 44. Middle East & Africa Alzheimer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 45. Middle East & Africa Alzheimer Market Size by Country (2018-2023) & (US$ Million)

    Table 46. Middle East & Africa Alzheimer Market Size by Country (2024-2029) & (US$ Million)

    Table 47. Allergan Company Detail

    Table 48. Allergan Business Overview

    Table 49. Allergan Alzheimer Product

    Table 50. Allergan Revenue in Alzheimer Business (2018-2023) & (US$ Million)

    Table 51. Allergan Recent Development

    Table 52. Eisai Company Detail

    Table 53. Eisai Business Overview

    Table 54. Eisai Alzheimer Product

    Table 55. Eisai Revenue in Alzheimer Business (2018-2023) & (US$ Million)

    Table 56. Eisai Recent Development

    Table 57. Novartis Company Detail

    Table 58. Novartis Business Overview

    Table 59. Novartis Alzheimer Product

    Table 60. Novartis Revenue in Alzheimer Business (2018-2023) & (US$ Million)

    Table 61. Novartis Recent Development

    Table 62. Daiichi Sankyo Company Detail

    Table 63. Daiichi Sankyo Business Overview

    Table 64. Daiichi Sankyo Alzheimer Product

    Table 65. Daiichi Sankyo Revenue in Alzheimer Business (2018-2023) & (US$ Million)

    Table 66. Daiichi Sankyo Recent Development

    Table 67. Merz Pharma Company Detail

    Table 68. Merz Pharma Business Overview

    Table 69. Merz Pharma Alzheimer Product

    Table 70. Merz Pharma Revenue in Alzheimer Business (2018-2023) & (US$ Million)

    Table 71. Merz Pharma Recent Development

    Table 72. Pfizer Company Detail

    Table 73. Pfizer Business Overview

    Table 74. Pfizer Alzheimer Product

    Table 75. Pfizer Revenue in Alzheimer Business (2018-2023) & (US$ Million)

    Table 76. Pfizer Recent Development

    Table 77. Johnson & Johnson Company Detail

    Table 78. Johnson & Johnson Business Overview

    Table 79. Johnson & Johnson Alzheimer Product

    Table 80. Johnson & Johnson Revenue in Alzheimer Business (2018-2023) & (US$ Million)

    Table 81. Johnson & Johnson Recent Development

    Table 82. Lundbeck Company Detail

    Table 83. Lundbeck Business Overview

    Table 84. Lundbeck Alzheimer Product

    Table 85. Lundbeck Revenue in Alzheimer Business (2018-2023) & (US$ Million)

    Table 86. Lundbeck Recent Development

    Table 87. Research Programs/Design for This Report

    Table 88. Key Data Information from Secondary Sources

    Table 89. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Alzheimer Market Size Comparison by Drug Type (2023-2029) & (US$ Million)

    Figure 2. Global Alzheimer Market Share by Drug Type: 2022 VS 2029

    Figure 3. Cholinesterase inhibitors Features

    Figure 4. Pipeline Drugs Features

    Figure 5. NMDA receptor antagonist Features

    Figure 6. Global Alzheimer Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Alzheimer Market Share by Application: 2022 VS 2029

    Figure 8. Hospital Pharmacy Case Studies

    Figure 9. Retail Pharmacy Case Studies

    Figure 10. Online Sales Case Studies

    Figure 11. Alzheimer Report Years Considered

    Figure 12. Global Alzheimer Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 13. Global Alzheimer Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 14. Global Alzheimer Market Share by Region: 2022 VS 2029

    Figure 15. Global Alzheimer Market Share by Players in 2022

    Figure 16. Global Top Alzheimer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer as of 2022)

    Figure 17. The Top 10 and 5 Players Market Share by Alzheimer Revenue in 2022

    Figure 18. North America Alzheimer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 19. North America Alzheimer Market Share by Country (2018-2029)

    Figure 20. United States Alzheimer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Canada Alzheimer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Europe Alzheimer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Alzheimer Market Share by Country (2018-2029)

    Figure 24. Germany Alzheimer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. France Alzheimer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. U.K. Alzheimer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Italy Alzheimer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Russia Alzheimer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Nordic Countries Alzheimer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Asia-Pacific Alzheimer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Alzheimer Market Share by Region (2018-2029)

    Figure 32. China Alzheimer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Japan Alzheimer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. South Korea Alzheimer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Southeast Asia Alzheimer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. India Alzheimer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Australia Alzheimer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Latin America Alzheimer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Alzheimer Market Share by Country (2018-2029)

    Figure 40. Mexico Alzheimer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Brazil Alzheimer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Middle East & Africa Alzheimer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Alzheimer Market Share by Country (2018-2029)

    Figure 44. Turkey Alzheimer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Saudi Arabia Alzheimer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Allergan Revenue Growth Rate in Alzheimer Business (2018-2023)

    Figure 47. Eisai Revenue Growth Rate in Alzheimer Business (2018-2023)

    Figure 48. Novartis Revenue Growth Rate in Alzheimer Business (2018-2023)

    Figure 49. Daiichi Sankyo Revenue Growth Rate in Alzheimer Business (2018-2023)

    Figure 50. Merz Pharma Revenue Growth Rate in Alzheimer Business (2018-2023)

    Figure 51. Pfizer Revenue Growth Rate in Alzheimer Business (2018-2023)

    Figure 52. Johnson & Johnson Revenue Growth Rate in Alzheimer Business (2018-2023)

    Figure 53. Lundbeck Revenue Growth Rate in Alzheimer Business (2018-2023)

    Figure 54. Bottom-up and Top-down Approaches for This Report

    Figure 55. Data Triangulation

    Figure 56. Key Executives Interviewed